Discovery of nuclear speckles may improve cancer treatment decisions

FHS
January 2, 2025
11:07 am

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to explain why.

Innovent and ASK Pharm partner to commercialise limertinib

Limertinib is intended for the treatment of patients with lung cancer. Credit: New Africa/Shutterstock. Innovent Biologics and Jiangsu Aosaikang Pharmaceutical (ASK Pharm) have signed a

October 8, 2024

Hiatal Hernia Repair With Mesh Did Not Reduce Hernia Recurrence Over the Long Term

Tension-free crural repair with nonabsorbable mesh did not reduce the incidence of hiatal hernia recurrence in patients undergoing antireflux surgery for treatment of gastroesophageal reflux

October 18, 2023

Chronic inflammation’s influence on TP53 mutations in leukemia evolution explored in new study

Researchers performed a multi-omics evaluation of HSPCs obtained from individuals with myeloproliferative neoplasms transforming to TP53-related secondary forms of acute myeloid leukemia.

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.